Latest News about psychedelics
Recent news which mentions psychedelics
Moving Closer To Cybin Acquisition, Small Pharma Obtains Final Order Approving Arrangement
October 18, 2023
From Benzinga
From Benzinga
Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M
October 17, 2023
Tickers
LSDI
From Benzinga
'The Third Wave Of Rescheduling': Experts Discuss How Plant Medicine Is Taking Share From Big Pharma
October 17, 2023
Tickers
CCC
From Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
October 17, 2023
Tickers
JNJ
From Benzinga
EXCLUSIVE: Close Up On Reason For Hope's Advocacy & Congressional Breakthrough Therapies Act
October 17, 2023
From Benzinga
Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts
October 16, 2023
From Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
October 16, 2023
From Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
October 15, 2023
Tickers
AWKNF
From Benzinga
Revolutionizing Psychiatry: More Than 80% Of Psychiatrists See Promise In Psychedelics Or Hallucinogens
October 15, 2023
From Benzinga
Psychedelics Firm Optimind Pharma Sustains Growth Plan Rollout With New Acquisition
October 13, 2023
From Benzinga
Dem Presidential Candidate Calls For Universal Healthcare, Including Psychedelics Therapy
October 13, 2023
From Benzinga
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
October 13, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.